Fatigue News and Research

RSS

Parkinson's drug may ease anhedonia in treatment-resistant depression

For many people who suffer from depression, the condition is not just about feeling down, but also about a loss of motivation and difficulty finding pleasure in activities they used to enjoy.

12 Jun 2026

Saliva biomarkers can directly detect acute sleep deprivation

A research team at the University of Zurich (UZH) has discovered biomarkers of sleep loss in saliva. Acute sleep deprivation can be detected using just a single saliva sample.

12 Jun 2026

Antibody profiles offer insights into long Covid cognitive symptoms

Persistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute infections has declined.

12 Jun 2026

Study identifies an important driver of inflammatory bowel disease

Researchers at the Nuffield Department of Medicine, University of Oxford, together with Newcastle University's Translational and Clinical Research Institute and the Department of Immunology at Cambridge University Hospitals NHS Foundation Trust, have identified an important driver of inflammatory bowel disease (IBD).

10 Jun 2026

GSV hospitals achieve substantially higher delirium screening in older surgical patients

There is a stark gap in how often hospitals screen older adults for postoperative delirium, with verified geriatric surgery programs screening nearly every patient while non-accredited programs screen just half, according to new findings published in the Journal of the American College of Surgeons.

10 Jun 2026

Sparkling water may leave you less hydrated after exercise

Electrolyte supplementation in carbonated water boosts fluid retention post-dehydration, making it a better rehydration option than plain sparkling water.

10 Jun 2026

Statins may help prevent frailty in older adults

Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering medications may have healthy aging benefits beyond cardiovascular disease prevention. Results are published in the European Heart Journal.

9 Jun 2026

Apitegromab helps tirzepatide users lose fat while preserving lean mass

A phase 2 trial found that apitegromab plus tirzepatide reduced lean body mass loss by 1.9 kg compared with tirzepatide plus placebo after 24 weeks, while overall weight loss remained similar.

9 Jun 2026

Extreme heat disrupts treatment and daily routines for cancer patients

New research published in the journal Environmental Research: Climate found that extreme heat is already influencing how people with cancer manage daily life, access care, and make treatment-related decisions.

9 Jun 2026

Study explains why walking slows and tires with age

Reasons why our walking becomes slower and more tiring with age have been uncovered by new Australian research - with findings showing the body increasingly sacrifices efficiency to stay upright.

9 Jun 2026

Review finds vitamin D lacks disease-modifying effect in rheumatic diseases

A new review from the International Osteoporosis Foundation (IOF) Osteoimmunology Working Group, published in Osteoporosis International, provides a comprehensive evaluation of the role of vitamin D in inflammatory rheumatic diseases.

8 Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

8 Jun 2026

Researchers induce sleep-like brain activity to reverse memory loss

By inducing specific patterns of activity in small portions of the brain in awake mice, researchers supported by the National Institutes of Health (NIH) have triggered a recalibration of neural connections that normally only occurs during sleep.

8 Jun 2026

Patient organizations strengthen support for people with rheumatic diseases

Rheumatic and musculoskeletal diseases (RMD) are chronic, often lifelong conditions. EULAR - The European Alliance of Associations for Rheumatology - works with the network of national organizations of People with Arthritis/Rheumatism in Europe (PARE) to ensure the voices of people with RMD are heard and have influence among decision makers - creating powerful alliances that make a real difference to lives.

7 Jun 2026

Biopsy-driven treatment strategy improves clinical outcomes in psoriatic arthritis

The management of psoriatic arthritis is increasingly focused on the early identification of clinical, immunological, and tissue-based phenotypes predictive of therapeutic response.

5 Jun 2026

EULAR Congress highlights innovative support strategies for rheumatology patients

Rheumatic and musculoskeletal diseases (RMD) profoundly impact daily life, limiting both work ability and participation in everyday activities.

5 Jun 2026

New data confirms dengue vaccine safety for older and chronic-risk travelers

Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests that the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic.

4 Jun 2026

Histamine boost helps the brain remember, decide, and learn from loss

Pitolisant, a histamine H3 receptor inverse agonist, improved recognition memory, working memory performance, and reinforcement learning in healthy adults. The findings suggest that histamine helps shape how the brain stabilizes new memories, accumulates evidence for decisions, and avoids overreacting to negative outcomes.

3 Jun 2026

Patented technology enables real-time detection of surgical bleeding sources

The United States Patent and Trademark Office (USPTO) officially issued a new patent to Wayne State University and RediMinds Inc. of Southfield, Michigan. The patent protects a pioneering technological advancement developed in the university's laboratories.

3 Jun 2026

New PET imaging approach quantifies synaptic pathology in multiple sclerosis

A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the brain's functional wiring in patients with multiple sclerosis.

2 Jun 2026